Bionomics Ltd has a consensus price target of $18.71 based on the ratings of 15 analysis. The 3 most-recent analyst ratings were released by HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on June 12, 2024, March 21, 2024, and December 7, 2023, respectively. With an average price target of $8 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 1076.47% upside for Bionomics Ltd from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/12/2024 | Buy Now | 1076.47% | HC Wainwright & Co. | Joseph Pantginis | $8 → $8 | Reiterates | Buy → Buy | Get Alert |
03/21/2024 | Buy Now | 1076.47% | HC Wainwright & Co. | Joseph Pantginis | → $8 | Reiterates | Buy → Buy | Get Alert |
12/07/2023 | Buy Now | 1076.47% | HC Wainwright & Co. | Joseph Pantginis | → $8 | Reiterates | Buy → Buy | Get Alert |
09/28/2023 | Buy Now | 1370.59% | Maxim Group | Jason McCarthy | $7 → $10 | Maintains | Buy | Get Alert |
09/28/2023 | Buy Now | 1076.47% | HC Wainwright & Co. | Joseph Pantginis | → $8 | Upgrade | Neutral → Buy | Get Alert |
06/16/2023 | Buy Now | 929.41% | Maxim Group | Jason McCarthy | → $7 | Initiates | → Buy | Get Alert |
03/10/2023 | Buy Now | 782.35% | Evercore ISI Group | Joshua Schimmer | → $6 | Upgrade | In-Line → Outperform | Get Alert |
03/09/2023 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis | — | Maintains | Neutral | Get Alert |
03/09/2023 | Buy Now | 2400% | Loop Capital | Esther Hong | $10 → $17 | Maintains | Buy | Get Alert |
12/20/2022 | Buy Now | 782.35% | Evercore ISI Group | Joshua Schimmer | $17 → $6 | Downgrade | Outperform → In-Line | Get Alert |
12/19/2022 | Buy Now | — | HC Wainwright & Co. | Joseph Pantginis | — | Downgrade | Buy → Neutral | Get Alert |
11/01/2022 | Buy Now | 3282.35% | Loop Capital | Esther Hong | → $23 | Initiates | → Buy | Get Alert |
01/10/2022 | Buy Now | 7547.06% | Cantor Fitzgerald | Charles Duncan | → $52 | Initiates | → Overweight | Get Alert |
01/10/2022 | Buy Now | 2400% | Evercore ISI Group | Maneka Mirchandaney | → $17 | Initiates | → Outperform | Get Alert |
01/10/2022 | Buy Now | 2988.24% | Berenberg | Esther Hong | → $21 | Initiates | → Buy | Get Alert |
The latest price target for Bionomics (NASDAQ:BNOX) was reported by HC Wainwright & Co. on June 12, 2024. The analyst firm set a price target for $8.00 expecting BNOX to rise to within 12 months (a possible 1076.47% upside). 5 analyst firms have reported ratings in the last year.
The latest analyst rating for Bionomics (NASDAQ:BNOX) was provided by HC Wainwright & Co., and Bionomics reiterated their buy rating.
The last upgrade for Bionomics Ltd happened on September 28, 2023 when HC Wainwright & Co. raised their price target to $8. HC Wainwright & Co. previously had a neutral for Bionomics Ltd.
The last downgrade for Bionomics Ltd happened on December 20, 2022 when Evercore ISI Group changed their price target from $17 to $6 for Bionomics Ltd.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bionomics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bionomics was filed on June 12, 2024 so you should expect the next rating to be made available sometime around June 12, 2025.
While ratings are subjective and will change, the latest Bionomics (BNOX) rating was a reiterated with a price target of $8.00 to $8.00. The current price Bionomics (BNOX) is trading at is $0.68, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.